Health Care Down as Traders Bet on Growth Areas -- Health-Care Roundup
August 29 2014 - 5:08PM
Dow Jones News
Drug makers and health insurers fell slightly as traders hedged
their bets on the outlook for deal activity and drug developments.
Johnson & Johnson and Bayer AG announced plans Friday to launch
clinical trials of the anticoagulant Xarelto against three new
diseases in an ambitious bid to widen the market for a drug poised
to exceed $1 billion in sales this year.
-Rob Curran, rob.curran@dowjones.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Apr 2023 to Apr 2024